Drug Shortage Report for DEPO-PROVERA

Last updated on 2022-12-20 History
Report ID 131486
Drug Identification Number 00585092
Brand name DEPO-PROVERA STERILE AQUEOUS SUSPENSION 150 MG/ML
Common or Proper name DEPO-PROVERA
Company Name PFIZER CANADA ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) MEDROXYPROGESTERONE ACETATE
Strength(s) 150MG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 1 x 1ML
ATC code G03AC
ATC description HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-07-23
Actual start date 2021-07-21
Estimated end date 2023-06-01
Actual end date 2022-08-05
Shortage status Resolved
Updated date 2022-12-20
Company comments Product discontinued, see posting 178953. Other presentation available, pre-filled syringes (DIN 02523493)
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: [email protected]

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v28 2022-12-20 French Compare
v27 2022-12-20 English Compare
v26 2022-07-21 English Compare
v25 2022-06-29 French Compare
v24 2022-06-29 English Compare
v23 2022-01-13 English Compare
v22 2021-09-30 French Compare
v21 2021-09-30 English Compare
v20 2021-07-22 English Compare
v19 2021-07-21 French Compare
v18 2021-07-21 English Compare
v17 2021-07-20 French Compare
v16 2021-07-20 English Compare
v15 2021-07-20 English Compare
v14 2021-07-14 French Compare
v13 2021-07-14 English Compare
v12 2021-05-21 French Compare
v11 2021-05-21 English Compare
v10 2021-04-09 French Compare
v9 2021-04-09 English Compare

Showing 1 to 20 of 28